SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
Commission File Number: 001-03753
(Check One):
[ } Form 10-K and Form 10-KSB [ ] Form 11-K
[ ] Form 20-F [X] Form 10-Q and Form 10-QSB [ ] Form N-SAR
For Period Ended: September 30, 2000
Transition Report on Form 10-K
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q
Transition Report on Form N-SAR
For the Transition Period Ended: ______________________
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates: Not applicable
Part I
Registrant Information
Full name of registrant: REMEDENT USA, INC.
Former Name if Applicable: Not applicable
Address of principal executive office (Street and number): 1220 Birch Way
City, state and zip code: Escondido, California 92027
<PAGE>
PART II
RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate).
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be
filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report or transition report on Form
10-Q, or portion thereof will be filed on or before the fifth calendar
day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
Part III
Narrative Response
State below in reasonable detail the reasons why Form 10-K, 10-KSB,
20-F, 11-K, 10-Q, 10-QSB, N-SAR or the transition report or portion thereof
could not be filed within the prescribed period. (ATTACH EXTRA SHEETS IF NEEDED)
The Registrant's Quarterly Report on Form 10-Q for the fiscal quarter
ended September 30, 2000 could not be filed within the prescribed time period
because those involved in the preparation of the Registrant's financial
statements were working on an amendment to the Registrant's registration
statement on form 10-SB and responding to the Commissions comment letter and
were not able to complete the required financial statements without unreasonable
effort or expense. The amendment to the 10-SB was filed with the Commission on
November 6, 2000.
Part IV
Other Information
(1) Name and telephone number of person to contact in regard to this
notification
Rebecca Inzuna (706) 781-3333
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s).
[X} Yes [ ] No
<PAGE>
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
REMEDENT USA, INC.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Dated November 14, 2000 By /s/ Rebecca Inzunza
-------------------
Rebecca Inzunza, President
